Physician profile
Maria Tasso
NPI 1003924457
$865.97
in general payments reported to CMS, 2019-2025
13 companies · $275 in 2025
The $275 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $29.99 · 2021: $12.55 · 2022: $15.28 · 2023: $180 · 2024: $63.80 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $241.29 | 2019-2025 | |
| Pfizer INC. | $178.19 | 2019-2025 | |
| Tris Pharma INC | $77.25 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $66.21 | 2022-2025 | Gardasil 9, Proquad, Vaxelis |
| Corium, LLC | $53.66 | 2023 | Azstarys |
| Cranial Technologies, INC | $49.60 | 2019-2025 | Doc Band |
| Glaxosmithkline, LLC. | $49.49 | 2019-2024 | Bexsero, Rotarix |
| Alk-Abello, INC | $43.76 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $39.23 | 2023-2024 | Jornay Pm |
| Cumberland Pharmaceuticals, INC. | $19.42 | 2023 | Kristalose |
| Kaleo, INC. | $19.06 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.64 | 2020 | |
| Adlon Therapeutics L.P. | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Tasso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.